Randomized Trial of Endocrine Therapy Against Locoregional Therapy First. A DBCG Trial in Postmenopausal Patients With Operable Hormone Receptor Positive Tumors Larger Than 2 cm.

Trial Profile

Randomized Trial of Endocrine Therapy Against Locoregional Therapy First. A DBCG Trial in Postmenopausal Patients With Operable Hormone Receptor Positive Tumors Larger Than 2 cm.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 19 Feb 2015

At a glance

  • Drugs Letrozole (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Acronyms DBCG; REAL
  • Most Recent Events

    • 20 Apr 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
    • 20 Apr 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2008-005067-33).
    • 02 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top